Pure Bioscience, Inc. SEC filings PURE

Pure Bioscience, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to May 24, 1996. Its latest annual report, Form 10-K, was filed on Oct 29, 2026 for the period ended Jul 31, 2026. The latest quarterly report (Form 10-Q) was filed on Jun 15, 2026, covering the quarter ended Apr 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on July 31.

Pure Bioscience, Inc. SEC filings
Form Description Filed Period
10-K Annual report Oct 29, 2026 Jul 31, 2026
10-K Annual report Oct 29, 2025 Jul 31, 2025
10-K Annual report Oct 29, 2024 Jul 31, 2024
10-K Annual report Oct 30, 2023 Jul 31, 2023
10-K Annual report Oct 28, 2022 Jul 31, 2022
10-K Annual report Oct 28, 2021 Jul 31, 2021
10-K Annual report Oct 8, 2020 Jul 31, 2020
10-K Annual report Oct 30, 2019 Jul 31, 2019
10-K Annual report Oct 25, 2018 Jul 31, 2018
10-K Annual report Oct 26, 2017 Jul 31, 2017
10-K Annual report Oct 27, 2016 Jul 31, 2016
10-K Annual report Oct 28, 2015 Jul 31, 2015
10-K Annual report Oct 28, 2014 Jul 31, 2014
10-K Annual report Oct 24, 2013 Jul 31, 2013
10-K Annual report Oct 29, 2012 Jul 31, 2012
10-K Annual report Oct 31, 2011 Jul 31, 2011
10-K/A Amended annual report Dec 6, 2010 Jul 31, 2010
10-K Annual report Oct 28, 2010 Jul 31, 2010
10-K Annual report Oct 13, 2009 Jul 31, 2009
10-K Annual report Oct 14, 2008 Jul 31, 2008

Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Miscellaneous Chemical Products (SIC 2890)
Listed as
PURE (OTC)
Fiscal year ends
July 31
Incorporated in
DE
Headquarters
El Cajon, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1006028
Former names
PURE BIOSCIENCE (until Mar 17, 2011); INNOVATIVE MEDICAL SERVICES (until Sep 2, 2003)

Other Miscellaneous Chemical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.